✦ LIBER ✦

Long-Term Outcome of Phase I/II Clinical Trial of Ad-OC-TK/VAL Gene Therapy for Hormone-Refractory Metastatic Prostate Cancer

✍ Scribed by Shirakawa, Toshiro; Terao, Shuji; Hinata, Nobuyuki; Tanaka, Kazushi; Takenaka, Atsushi; Hara, Isao; Sugimura, Kazuro; Matsuo, Masafumi; Hamada, Katsuyuki; Fuji, Kohzo; Okegawa, Takatsugu; Higashihara, Eiji; Gardner, Thomas A.; Kao, Chinghai; Chung, Leland W.K.; Kamidono, Sadao; Fujisawa, Masato; Gotoh, Akinobu

Book ID: 127118619
Publisher: Mary Ann Liebert
Year: 2007
Tongue: English
Weight: 239 KB
Volume: 18
Category: Article
ISSN: 1043-0342
DOI: 10.1089/hum.2007.074

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progress report on phase I/II clinical t

Progress report on phase I/II clinical trial of Ad-OC-TK plus VAL therapy for metastatic or locally recurrent prostate cancer: Initial experience at Kobe University

✍ NOBUYUKI HINATA; TOSHIRO SHIRAKAWA; SHUJI TERAO; KAZUMASA GODA; KAZUSHI TANAKA; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Long-term Outcome of a Phase II Trial Co

Long-term Outcome of a Phase II Trial Combining in Situ Gene Therapy and Intensity Modulated Radiotherapy With or Without Hormonal Therapy for Prostate Cancer

✍ B.S. Teh; H. Ishiyama; B. Xu; G. Ayala; T. Wheeler; D. Kadmon; A.C. Paulino; A.I 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 62 KB